302 related articles for article (PubMed ID: 19176987)
1. Protease-activated receptors, apoptosis and tumor growth.
Borensztajn KS; Spek CA
Pathophysiol Haemost Thromb; 2008; 36(3-4):137-47. PubMed ID: 19176987
[TBL] [Abstract][Full Text] [Related]
2. Protease signaling in tumor progression.
Camerer E
Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
[TBL] [Abstract][Full Text] [Related]
3. Overview of the postulated mechanisms linking cancer and thrombosis.
ten Cate H; Falanga A
Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
[TBL] [Abstract][Full Text] [Related]
4. The cardiovascular actions of protease-activated receptors.
Steinberg SF
Mol Pharmacol; 2005 Jan; 67(1):2-11. PubMed ID: 15371558
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
Arora P; Ricks TK; Trejo J
J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
[TBL] [Abstract][Full Text] [Related]
6. Protease activated receptors in cardiovascular function and disease.
Barnes JA; Singh S; Gomes AV
Mol Cell Biochem; 2004 Aug; 263(1-2):227-39. PubMed ID: 15524183
[TBL] [Abstract][Full Text] [Related]
7. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors: contribution to physiology and disease.
Ossovskaya VS; Bunnett NW
Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor and cancer stem cells: is there a linkage?
Milsom C; Magnus N; Meehan B; Al-Nedawi K; Garnier D; Rak J
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2005-14. PubMed ID: 19628788
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor and cancer.
Milsom C; Rak J
Pathophysiol Haemost Thromb; 2008; 36(3-4):160-76. PubMed ID: 19176989
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
Luo W; Wang Y; Reiser G
Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
[TBL] [Abstract][Full Text] [Related]
12. Structure, function and pathophysiology of protease activated receptors.
Adams MN; Ramachandran R; Yau MK; Suen JY; Fairlie DP; Hollenberg MD; Hooper JD
Pharmacol Ther; 2011 Jun; 130(3):248-82. PubMed ID: 21277892
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor and PAR signaling in tumor progression.
Ruf W
Thromb Res; 2007; 120 Suppl 2():S7-12. PubMed ID: 18023716
[TBL] [Abstract][Full Text] [Related]
14. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
[TBL] [Abstract][Full Text] [Related]
15. Thrombin signaling in the brain: the role of protease-activated receptors.
Wang H; Reiser G
Biol Chem; 2003 Feb; 384(2):193-202. PubMed ID: 12675511
[TBL] [Abstract][Full Text] [Related]
16. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor and protease-activated receptor signaling in cancer.
Schaffner F; Ruf W
Semin Thromb Hemost; 2008 Mar; 34(2):147-53. PubMed ID: 18645919
[TBL] [Abstract][Full Text] [Related]
18. Activation of clotting factors in cancer.
Rickles FR; Falanga A
Cancer Treat Res; 2009; 148():31-41. PubMed ID: 19377917
[No Abstract] [Full Text] [Related]
19. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated activation of heterotrimeric G-proteins: current structural insights.
Johnston CA; Siderovski DP
Mol Pharmacol; 2007 Aug; 72(2):219-30. PubMed ID: 17430994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
